iRhythm Technologies Inc IRTC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IRTC is a good fit for your portfolio.
News
-
New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
-
iRhythm Technologies Announces Third Quarter 2023 Financial Results
-
iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023
-
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
Trading Information
- Previous Close Price
- $86.87
- Day Range
- $85.43–89.58
- 52-Week Range
- $70.24–140.23
- Bid/Ask
- $35.77 / $89.14
- Market Cap
- $2.73 Bil
- Volume/Avg
- 339,948 / 382,267
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.73
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,793
- Website
- https://www.irhythmtech.com
Valuation
|
Metric
|
IRTC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 12.43 |
Price/Sales | 5.73 |
Price/Cash Flow | 58.50 |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IRTC
|
|---|---|
Quick Ratio | 2.04 |
Current Ratio | 2.29 |
Interest Coverage | −28.11 |
Quick Ratio
IRTC
Profitability
|
Metric
|
IRTC
|
|---|---|
Return on Assets (Normalized) | −20.30% |
Return on Equity (Normalized) | −38.65% |
Return on Invested Capital (Normalized) | −24.69% |
Return on Assets
IRTC
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ABT
| Abbott Laboratories | Crvrrf | $181.4 Bil | |
SYK
| Stryker Corp | Mfmk | $109.8 Bil | |
MDT
| Medtronic PLC | Jtdsm | $105.5 Bil | |
BSX
| Boston Scientific Corp | Pybcgl | $80.5 Bil | |
DXCM
| DexCom Inc | Xbl | $44.6 Bil | |
EW
| Edwards Lifesciences Corp | Mpshfv | $42.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Kvcrr | $24.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Dwryfy | $18.6 Bil | |
ALGN
| Align Technology Inc | Tblns | $16.9 Bil | |
PODD
| Insulet Corp | Xhmzty | $13.6 Bil |